good news. Volume up. Opinion only. Not a professional recommendation
good news. Volume up. Opinion only. Not a professional recommendation
Opinion only, not professional advice ! Inflation, tapering, money out of the market. Futures do not show a crash yet. If VIX passes the 40 a slippery slope can end in a crash.
Hi An interesting phenomenon is that the ETF drops from a peak height to the bottom 480-500 BARS daily, weekly every 100 BARS, monthly every 23 BARS. According to the calculation it is supposed to jump up by February 22nd. The last decline cycle from March 2020 is the strongest and the volumes are much larger ....... it may cause the jump up to be more...
Hysteria of the large funds that hold shorts causes a drop in price and panic. Anyone who looks at MRNA can see exactly the same pattern of action in April 2020. After approval from the World Health Organization there is no reason to move down No financial advice!
however it is difficult to do technical analysis for this ETF. And all the contracts on volatility seem to be in ok order. As soon as the spring will released it will fly. Not professional advice. Idea only
AIM post covid therapy treatment Big Market value potential About AIM ImmunoTech Inc. AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.
pinion only not professional advice. CYCLIC LINES Games with tools ......
Idea only not professional advice BIOLASE Reports 70% Revenue Growth In First Quarter 2021; Continued High Demand From New Users For Dental Lasers. 2021 First Quarter Operating Highlights (all comparisons are on a year over year basis): Net revenue grew 70% to $8.1 million with: Laser system sales increased 139% Consumables and other revenue increased...
All the indicators show that something could happen at any moment ... Inflation is starting to climb. The virus is still here. The economic situation on the street is the opposite of the stock market. A lot of money has come out of assets in the last month. The Fed in a last-ditch effort is holding the market, the “reassuring” messages. the VIX fear index is...
NanoViricides, Inc. Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical Cell Culture Studies Performed in Preparation of FDA Pre-IND Application
Enlivex and Mount Sinai Health System Announce Research Collaboration for the Development of Allocetra in Combination with Immune Checkpoint Inhibitors. In addition to the Sepsis for which it was developed, the drug Allocetra has other applications such as severe patients with Covid 19 ' autoimmune diseases. Indication Global Market Size Pre Clinical Phase ...
The drug Allocetra saves the lives of patients in a severe condition from the virus in Israel. The end of the Phase 2 trial is about to be published soon. preventing or treating complications associated with sepsis, COVID-19, bone-marrow transplants and solid tumors. At the end of 2021, the drug report on patients will be published. Last chance before takeoff. ...
The virus is still here, protective equipment will be needed even after the vaccine. The company's sales are excellent. Selling reality and not dreams ...